Skip to main content
. 2021 Jun 15;2021:9935451. doi: 10.1155/2021/9935451

Figure 2.

Figure 2

Anticancer activity of wogonin (a) in breast cancer cell lines (TNBC), (b) in gastric cancer cell lines (SGC-7901), and (c) in colorectal cancer cell lines (CRC HCT-116). Wogonin acts as anticancer agent mainly by inhibiting the cell cycle through downregulating cyclins and inducing apoptosis in the cancerous cells.